Sign in →

Test ID MCLBP MayoComplete Liquid Biopsy Panel, Next-Generation Sequencing, Cell-Free DNA

Ordering Guidance

This test is not a prenatal screening test. For prenatal screening, consider QUAD1 / Quad Screen (Second Trimester) Maternal, Serum.

Shipping Instructions

1. Specimens should be transported at ambient or refrigerated (4° C) temperature.

2. Specimens are viable for 7 days when collected using the Streck Black/Tan Top Tube Kit.

Necessary Information

Paperwork (pathology report, oncology request form, or similar document) that indicates the cancer diagnosis must be provided. Testing may proceed without this information; however, it aids in providing a more thorough and accurate interpretation of results. Ordering providers are strongly encouraged to provide the information and send with the specimen.

Specimen Required

Supplies: Streck Black/Tan Top Tube Kit (T715)

Container/Tube: Streck Cell-Free DNA (cfDNA) blood collection kit

Specimen Volume: Two 10-mL Streck Cell-Free DNA blood collection tubes

Additional Information: Only blood collected in Streck Cell-Free DNA BCT tubes will be accepted for analysis. Whole blood will be processed to produce platelet-poor plasma before cfDNA isolation.

Useful For

As an alternative to invasive tissue biopsies to assist in tumor profiling for diagnosis, predicting prognosis, and identifying targeted therapies for the treatment and management of patients with solid tumors


As an alternative to invasive tissue biopsies for assessment of microsatellite instability status

Method Name

Sequence Capture and Targeted Next-Generation Sequencing (NGS)

Reporting Name

MayoComplete Liquid Biopsy Panel

Specimen Type

Whole blood

Specimen Minimum Volume

One 10-mL Streck tube

Specimen Stability Information

Specimen Type Temperature Time Special Container
Whole blood Ambient (preferred) 7 days Streck Black/Tan top
  Refrigerated  7 days Streck Black/Tan top

Reference Values

An interpretive report will be provided.

Day(s) Performed

Monday through Friday

Report Available

7 to 10 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information


LOINC Code Information

Test ID Test Order Name Order LOINC Value
MCLBP MayoComplete Liquid Biopsy Panel 73977-1


Result ID Test Result Name Result LOINC Value
614940 Result Summary 50397-9
614465 Result 82939-0
614466 Interpretation 69047-9
614467 Additional Information 48767-8
614468 Specimen 31208-2
614469 Source 31208-2
614470 Method 85069-3
614471 Disclaimer 62364-5
614472 Released By 18771-6
MG143 Reason for Referral - Cancer Type 42349-1